SVA
Sinovac Biotech Ltd
NASDAQ: SVA · HEALTHCARE · BIOTECHNOLOGY
$6.47
+0.00% today
Updated 2026-04-29
Market cap
$642.44M
P/E ratio
6.66
P/S ratio
1.83x
EPS (TTM)
$0.97
Dividend yield
850.00%
52W range
$6 – $6
Volume
—
Sinovac Biotech Ltd (SVA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-266.7%
Most recent quarter
When is the next earnings report?
Reporting date
June 30, 2025
Consensus EPS estimate
—
Fiscal period ending
2025-06-30
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | — | — | — | — | — |
| 2024-06-30 | $-0.03 | $-0.11 | -266.7% | — | — |
| 2024-03-31 | $-0.03 | $-0.03 | +0.0% | — | — |
| 2023-12-31 | $-0.02 | $-0.04 | -100.0% | $307.87M | — |
| 2023-09-30 | $-0.02 | $-0.03 | -50.0% | — | — |
| 2023-06-30 | $-0.02 | $-0.03 | -50.0% | $140.40M | -88.4% |
| 2023-03-31 | $-0.02 | $-0.03 | -50.0% | $1.68B | — |
| 2022-12-31 | $-0.02 | $-0.03 | -50.0% | — | — |
| 2022-09-30 | $-0.02 | $-0.02 | +0.0% | $280.47M | -96.7% |
| 2022-06-30 | $0.00 | $0.00 | — | $1.21B | — |
| 2022-03-31 | $0.00 | $29.44 | — | — | — |
| 2021-09-30 | $0.00 | $0.00 | — | $8.39B | — |
Frequently asked questions
When does Sinovac Biotech Ltd report next earnings?
Sinovac Biotech Ltd (SVA) is scheduled to report earnings on June 30, 2025.
Has Sinovac Biotech Ltd beaten earnings estimates?
Sinovac Biotech Ltd has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports.